IRIS PubliCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.575
NA - Nord America 4.438
AS - Asia 725
AF - Africa 63
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 12.838
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.420
US - Stati Uniti d'America 4.404
DE - Germania 964
SE - Svezia 624
UA - Ucraina 512
CN - Cina 496
IE - Irlanda 257
FR - Francia 229
PL - Polonia 136
FI - Finlandia 126
GB - Regno Unito 106
IN - India 84
CI - Costa d'Avorio 48
TR - Turchia 36
RU - Federazione Russa 33
BE - Belgio 32
CH - Svizzera 30
JP - Giappone 29
CA - Canada 24
ES - Italia 23
IR - Iran 22
NL - Olanda 20
VN - Vietnam 12
MX - Messico 10
BR - Brasile 9
HK - Hong Kong 9
GR - Grecia 8
RO - Romania 8
BD - Bangladesh 7
SG - Singapore 7
AT - Austria 6
CL - Cile 6
CO - Colombia 6
TH - Thailandia 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
HU - Ungheria 4
SI - Slovenia 4
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
PH - Filippine 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
A1 - Anonimo 2
EU - Europa 2
IL - Israele 2
IS - Islanda 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SM - San Marino 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
HR - Croazia 1
ID - Indonesia 1
KR - Corea 1
LU - Lussemburgo 1
MN - Mongolia 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SD - Sudan 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 12.838
Salva come PNG Salva come JPEG
Città #
Chandler 1.019
Milan 518
Ashburn 348
Rome 317
San Mateo 246
Jacksonville 245
Dublin 243
Wilmington 162
New York 151
Nanjing 129
Ann Arbor 127
Naples 114
Fairfield 111
Boston 108
Lawrence 94
Cattolica 91
Dearborn 79
Turin 79
Beijing 74
Warsaw 72
Redwood City 67
Houston 59
Bologna 58
Florence 57
Princeton 53
Kraków 50
Nürnberg 49
Palermo 49
Abidjan 48
Woodbridge 48
Seattle 47
Nanchang 39
Bari 37
Genoa 37
Redmond 35
Mountain View 34
Catania 33
Chicago 32
Guangzhou 29
Hangzhou 29
Lancaster 29
Boardman 27
Norwalk 27
University Park 27
Shenyang 26
Brussels 25
Hebei 25
Izmir 25
Verona 25
Brescia 24
Marseille 23
Augusta 22
Padova 22
Perugia 22
Bremen 21
Kunming 20
Zhengzhou 20
Bergamo 19
Changsha 19
Leawood 18
Reggio Emilia 18
Messina 17
Helsinki 15
Jiaxing 15
Munich 15
Venice 14
Andover 13
Cagliari 13
Cambridge 13
Livorno 13
Taranto 13
Tianjin 13
Parma 12
Pune 12
Rimini 12
Salerno 12
Toronto 12
Novara 11
Pescara 11
Amsterdam 10
Detroit 10
Hanoi 10
Los Angeles 10
Piacenza 10
San Francisco 10
Trieste 10
Changchun 9
Shanghai 9
São Paulo 9
Udine 9
Benevento 8
Centro 8
Fremont 8
Hong Kong 8
Lucca 8
Portici 8
Radomsko 8
Busto Arsizio 7
Hefei 7
La Spezia 7
Totale 6.120
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 4.308
Accidental transplantation of a kidney with stones: case report 152
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 135
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 131
Belatacept utilization recommendations: an expert position 114
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 113
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 111
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 111
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 109
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 108
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 106
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 106
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 105
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 99
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 95
Interventional radiological treatment of renal transplant complications: a pictorial review 94
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 91
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 90
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 88
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 87
Complete clinical remission of psoriasis 6 months after renal transplantation 87
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 86
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 84
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 82
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 82
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 81
Significant improvement in patient survival after renal transplantation in the last decade. 81
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 80
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 80
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 80
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 79
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 79
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 78
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 77
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 76
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 74
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 72
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 72
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 71
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 70
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 69
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 68
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 68
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 68
Belatacept utilization recommendations: an expert position 67
Anonymity and live-donor transplantation: an ELPAT view 67
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 67
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 66
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 66
Evolution of causes of mortality in renal transplantation in the last 10 years 66
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 65
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 64
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 64
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 63
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 63
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 62
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 61
[Organ transplantation: training and prospects for a young surgeon] 61
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 60
Isoprinosine effects on postoperative immunodepression 60
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 60
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 60
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 59
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 59
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 59
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 59
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 59
Re: Complete Clinical Remission of Psoriasis 6 Months After Renal Transplantation Response 58
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 57
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 57
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 56
Belatacept utilization recommendations: an expert position 56
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 55
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 55
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 55
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 55
Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature 54
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 54
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 52
COVID-19 and kidney transplantation: an Italian Survey and Consensus 52
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 51
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results 51
Prediction, prevention, and management of delayed graft function: where are we now? 51
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 51
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 51
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study 50
Anonymity and live-donor transplantation: an ELPAT view 50
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 50
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 50
Outcome of liver transplatation after acute rejection and sepsis 49
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 49
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 49
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 49
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 48
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial 48
Interventional Radiological Treatment of Renal Transplant Complications: A Pictorial Review 48
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 48
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 48
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 48
De Novo Malignancies after Organ Transplantation: Focus on Viral Infections 47
Totale 11.336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 33 54 23
2019/2020926 215 29 49 18 24 39 105 19 49 41 193 145
2020/20211.146 71 125 29 125 157 100 125 31 152 33 176 22
2021/20221.331 84 125 27 52 46 55 37 227 48 98 264 268
2022/20233.771 329 346 191 448 177 429 151 338 490 203 384 285
2023/20243.887 284 572 300 373 340 486 400 417 349 366 0 0
Totale 12.965